Increased Luteinizing Hormone Secretion in Women with Polycystic Ovary Syndrome Is Unaltered by Prolonged Insulin Infusion
The DOI matches its Crossref record; 35 of the 46 references it cites were found in a registry or an index.
Abstract
In PCOS women with insulin resistance, hyperinsulinemia may contribute to inappropriate gonadotropin secretion. To determine whether insulin influences gonadotropin release in PCOS, pulsatile LH secretion and gonadotropin responses to GnRH were evaluated before (phase 1) and during (phase 2) insulin infusion. In phase 1, 11 PCOS and 9 normal women on separate days underwent 1) frequent blood sampling (q 10 min) for 12 h and 2) gonadotropin stimulation by successive doses of GnRH, 2 μg, 10 μg, and 20 μg, administered iv at 4 h intervals over a continuous 12 h. In phase 2, studies were repeated 2 h after initiation of a 12-h hyperinsulinemic-euglycemic clamp (80 mU/m2·min). Administration of insulin to both groups failed to alter mean serum gonadotropin concentrations, LH pulse frequency, or LH pulse amplitude. Moreover, gonadotropin responses to GnRH were unchanged by insulin infusion. In PCOS and normal women, a significant reduction of serum androstenedione was associated with insulin administration, whereas no differences were noted for the remaining androgens and estrogens measured. These findings demonstrated that in PCOS women, LH secretion and gonadotropin responses to GnRH were not influenced by insulin administration. Insulin infusion had little effect on steroid hormone production with the possible exception of androstenedione. These results suggest that inappropriate LH secretion in PCOS is not a direct consequence of insulin resistance and compensatory hyperinsulinemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., Polson, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 981
Kiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
YEN, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 698
Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660
Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
Dunaif, A., Scott, D., Finegood, D., Quintana, B., & Whitcomb, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 524
Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome
Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D., & Allan, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401703 · Cited by 518
Research works printed but not linked: 1
- Mortola, 1989, Yen SCC Insulin modulates gonadotropin release and gonadotrope sensitivity to GnRH in polycystic ovary syndrome and normal women
Cited by
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
Self-citationCassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Blank, S. K., McCartney, C. R., & Marshall, J. C. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml017 · Cited by 301
“exogenous insulin do not alter LH secretion (Dunaif and Graf, 1989; Patel et al., 2003; Mehta et al., 2005), and reduction of insulin in PCOS has inconsistent effects on LH levels (Poretsky et al.”
BackgroundThe relationship between gut and adipose hormones, and reproduction
Comninos, A. N., Jayasena, C. N., & Dhillo, W. S. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt033 · Cited by 167
“…PCOS (who characteristically have more frequent LH pulses, higher LH levels and higher LH/FSH ratios than normal women with regular menstrual cycles) have revealed no effect of a 12 h hyperinsulinaemic euglycaemic clamp on LH secretion (Patel et al., 2003; Mehta et al., 2005; Moret et al., 2009).”
InfluentialBrothers, K. J., Wu, S., DiVall, S. A., Messmer, M. R., Kahn, C. R., Miller, R. S., Radovick, S., Wondisford, F. E., & Wolfe, A. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.010 · Cited by 157
“Some groups have noted that in PCOS women, insulin injection caused circulating gonadotropin levels to decrease (Lawson et al., 2008; Mehta et al., 2005; Patel et al., 2003).”
BackgroundInfluentialGanie, M. A., Khurana, M. L., Eunice, M., Gulati, M., Dwivedi, S. N., & Ammini, A. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031780 · Cited by 151
“The excess insulin has been postulated to partly augment LH-stimulated androgen secretion from the ovarian tissues and partly to increase free androgens by decreasing circulating SHBG levels (50, 51 ).”
BackgroundPagán, Y. L., Srouji, S. S., Jimenez, Y., Emerson, A., Gill, S., & Hall, J. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2099 · Cited by 140
“Our findings are also consistent with two studies that failed to demonstrate an effect of insulin infusions on pulsatile LH secretion in women with PCOS (44, 45).”
ResultPolycystic Ovary Syndrome in Adolescence
Buggs, C., & Rosenfield, R. L. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.04.005 · Cited by 160
“Although in vivo studies have failed to show an effect of insulin on LH secretion in PCOS [26], there is emerging evidence suggesting that insulin nevertheless may enhance LH secretion.”
BackgroundAcupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial
Johansson, J., Redman, L., Veldhuis, P. P., Sazonova, A., Labrie, F., Holm, G., Johannsson, G., & Stener-Victorin, E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00039.2013 · Cited by 131
Silva, M. S. B., Desroziers, E., Hessler, S., Prescott, M., Coyle, C., Herbison, A. E., & Campbell, R. E. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.065 · Cited by 115
“associated with impaired steroid hormone negative feedback [7–9] and a hyperactive GnRH/LH system [6,10,11].”
Lerchbaum, E., Schwetz, V., Rabe, T., Giuliani, A., & Obermayer-Pietsch, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108263 · Cited by 110
“Interestingly, insulin infusion has been shown to lower androstenedione levels without an effect on testosterone or DHEAS levels [25].”
BackgroundTosi, F., Negri, C., Perrone, F., Dorizzi, R., Castello, R., Bonora, E., & Moghetti, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2939 · Cited by 90
Metabolic Fuel and Clinical Implications for Female Reproduction
Mircea, C. N., Lujan, M. E., & Pierson, R. A. (2007) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32661-5 · Cited by 100
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients
Genazzani, A. D., Santagni, S., Rattighieri, E., Chierchia, E., Despini, G., Marini, G., Prati, A., & Simoncini, T. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.897321 · Cited by 73
“In fact, before treatment, LH response was greater than normal, similar to previous report [33], but under DCI administration, LH response to GnRH decreased thus suggesting a primary role of insulin-dependent metabolic pathway(s) on pituitary functions and/or gonadotropes sensitivity to GnRH, as it has been demonstrat…”
ResultMoret, M., Stettler, R., Rodieux, F., Gaillard, R. C., Waeber, G., Wirthner, D., Giusti, V., Tappy, L., & Pralong, F. P. (2009) · Neuroendocrinology · doi:10.1159/000160911 · Cited by 72
Inositol and human reproduction. From cellular metabolism to clinical use
Milewska, E. M., Czyzyk, A., Meczekalski, B., & Genazzani, A. D. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1188282 · Cited by 69
“Additionally, insulin-dependent pathways influence the hypothalamic–pituitary function, so that GnRH induced LH release and the gonadotropin-induced ovarian androgen production are both increased [45].”
BackgroundReappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
Houston, E. J., & Templeman, N. M. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0269 · Cited by 109
“It can also act directly on the anterior pituitary to increase LH secretion in rodents (Adashi et al. 1981, Xia et al. 2001), although acutely infusing high insulin does not appear to further elevate LH in obese women with PCOS (Dunaif & Graf 1989, Patel et al. 2003, Lawson et al. 2008).”
Polycystic ovary syndrome: etiology and pathogenesis
Matalliotakis, I., Kourtis, A., Koukoura, O., & Panidis, D. (2006) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-006-0171-x · Cited by 87
“[46] that postulates that inappropriate LH secretion in PCOS is not a direct consequence of insulin resistance”
BackgroundGlintborg, D., Hermann, A. P., Andersen, M., Hagen, C., Beck‐Nielsen, H., Veldhuis, J. D., & Henriksen, J. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.067 · Cited by 73
Lawson, M. A., Jain, S., Sun, S., Patel, K., Malcolm, P. J., & Chang, R. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2656 · Cited by 67
“An effect of insulin infusion on GnRH-induced LH release in PCOS women was shown to be similar to that observed in normal women based on percent change from baseline (25, 26).”
MethodResultSelf-citationYoo, R. Y., Dewan, A. K., Basu, R., Newfield, R. S., Gottschalk, M. E., & Chang, R. J. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.037 · Cited by 65
Self-citationThe role of the endogenous opioid system in polycystic ovary syndrome
Eyvazzadeh, A. D., Pennington, K. P., Pop‐Busui, R., Sowers, M., Zubieta, J., & Smith, Y. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.012 · Cited by 56
Use of metformin in the treatment of polycystic ovary syndrome
Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51
“Metformin administration was reported to restore normal menstrual cyclicity in a high percentage of the patients affected by oligomenorrhea or amenorrhea [59,93,94], but was less effective than oral contraceptives [95,96].”
BackgroundResultInfluentialBarbotin, A., Mimouni, N. E. H., Kuchcinski, G., Lopes, R., Viard, R., Rasika, S., Mazur, D., Silva, M. S. B., Simon, V., Boursier, A., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104535 · Cited by 56
Mehta, R. V., Patel, K. S., Coffler, M. S., Dahan, M. H., Yoo, R. Y., Archer, J. S., Malcom, P. J., & Chang, R. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1040 · Cited by 47
Self-citationPolycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 36
Self-citationCardoso, R. C., Burns, A., Moeller, J., Skinner, D. C., & Padmanabhan, V. (2016) · Endocrinology · doi:10.1210/en.2016-1613 · Cited by 28
Neuroendocrine Dysfunction in PCOS: A Critique of Recent Reviews
Doi, S. A. R. (2008) · Clinical Medicine & Research · doi:10.3121/cmr.2008.796 · Cited by 27
Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome
Doi, S. A. R., Al-Zaid, M., Towers, P. A., Scott, C. J., & Al-Shoumer, K. A. S. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345319 · Cited by 26
Park, C.-H., & Chun, S. (2016) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2016.59.6.498 · Cited by 22
“[29], no changes in serum LH concentration or the pattern of LH secretion or changes in reactiveness to gonadotropin-releasing hormone following injection of insulin are observed in patients with PCOS; these results are partially consistent with our results.”
ResultChronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Insulin Resistance in Polycystic Ovarian Disease
Bhatia, V. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000177251.15366.85 · Cited by 15
GnRH pulse generator activity in mouse models of polycystic ovary syndrome
Zhou, Z., Han, S. Y., Pardo-Navarro, M., Wall, E. G., Desai, R., Vas, S., Handelsman, D. J., & Herbison, A. E. (2025) · eLife · doi:10.7554/elife.97179.3 · Cited by 17
“Nevertheless, we note that the PNA mouse clearly does not model women with PCOS that show a much-elevated LH response to GnRH ( Barnes et al., 1989 ; Batrinos, 1993 ; Morales et al., 1996 , Patel et al., 2003 ).”
Bellemare, V., Rotshenker-Olshinka, K., Nicholls, L., Digby, A. M., Pooni, A., Kadour‐Peero, E., Son, W., & Dahan, M. H. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02598-7 · Cited by 14
“PCOS patients display increased LH pulsatility favoring increased androgen production [6, 7].”
BackgroundSelf-citationUlloa‐Aguirre, A., Portocarrero-Ortiz, L. A., Zariñán, T., Olivares, A., Carranza‐Lira, S., Veldhuis, J. D., & López-Alvarenga, J. C. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61079-6 · Cited by 12
The Hypothalamic-Pituitary Axis in PCOS
Okigbo, C. C., Gill, S., & Hall, J. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_5 · Cited by 17
PCOS from Lifestyle to the Use of Inositol and Insulin Sensitizers
Genazzani, A. D., Prati, A., Despini, G., Marini, G. M. F., & Ricchieri, F. (2014) · ISGE series · doi:10.1007/978-3-319-03494-2_7 · Cited by 9
Altered multihormone synchrony in obese patients with polycystic ovary syndrome
Roelfsema, F., Kok, P., Veldhuis, J. D., & Pijl, H. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.011 · Cited by 7
Shim, A. R., Hwang, Y. I., Lim, K. J., Choi, Y., Jeon, Y. E., Seo, S. K., Cho, S., Choi, Y. S., & Lee, B. S. (2011) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2011.54.11.659 · Cited by 7
“이전의 연구에서 다낭성난소증 후군 환자에 인슐린을 주입한 후 혈중 LH 농도, LH 박동 진폭 및 빈도 가 주입 전과 비교하여 변화가 없었고 GnRH에 대한 LH의 반응성의 변 화도 없어서 부적절한 성선자극호르몬의 분비는 인슐린저항성이나 보 상성 고인슐린혈증과는 무관하다고 입증된 바 있으며[28] 인슐린 반응 성 증강제인 피오글리타존(pioglitazone) 투여 후에도 유사한 결과가 보 고 되었다[29].”
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00022-6 · Cited by 4
Self-citationSun, Z., Jin, B., Han, H., Qin, Z., Shi, Y., & Zhang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1661806 · Cited by 6
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00020-6 · Cited by 6
Self-citationPCOS and metformin: from pharmacology to clinical use for women's health
Genazzani, A. D., Ricchieri, F., Prati, A., Chierchia, E., Rattighieri, E., Bosco, G., Despini, G., Campedelli, A., Farinetti, A., & Santagni, S. (2012) · IRIS UNIMORE (University of Modena and Reggio Emilia) · Cited by 5
Pan, M., Zhang, J., Zhang, Q., Wang, F., Qu, F., & Jin, M. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5008162 · Cited by 2
“An increased LH/FSH ratio, as a marker of inappropriate gonadotropin secretion, which is one of the most characteristic hormonal features in PCOS, proved not to be the consequence of IR based on findings from a clinical trial [25,26].”
BackgroundYadav, R. P. (1970) · Nepal Journal of Obstetrics and Gynaecology · doi:10.3126/njog.v3i1.1431 · Cited by 1
Boyle, J. A. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 2
Polycystic Ovary Syndrome, Obesity and Insulin Resistance
Cassar, S. (2014) · Victoria University Research Repository (Victoria University) · Cited by 1
Gonadotropinspiegel bei gesunden Frauen und PCOS-Patientinnen: Einfluss von Hypo- und Hyperglykämie
Tauchert, S., Ludwig, A. K., Dietze, T., Diedrich, K., & Weiss, J. M. (2006) · Gynäkologische Endokrinologie · doi:10.1007/s10304-006-0153-x
“Es gibt amerikanische Studien, die zeigten, dass eine verlängerte Insulininfusion keinen Einfluss auf die LH-Sekretion hatte [13].”
BackgroundHypothalamic-Pituitary-Gonadotropic Dysfunction in the Polycystic Ovary Syndrome
Chang, R. J., & Mehta, R. V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_17
“Using the hyperinsulinemic-euglycemic clamp technique, our results demonstrated that episodic gonadotropin secretion and LH responses to multidose GnRH stimulation were not altered by insulin infusion over an interval of 12 hours in both groups ( 21 ).”
MethodSelf-citationGnRH pulse generator activity in mouse models of polycystic ovary syndromePreprint
Zhou, Z., Han, S. Y., Pardo-Navarro, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.04.597387
The GnRH pulse generator activity in mouse models of polycystic ovary syndromePreprint
Zhou, Z., Han, S. Y., Pardo-Navarro, M., Wall, E. G., Desai, R., Vas, S., Handelsman, D. J., & Herbison, A. E. (2024) · eLife · doi:10.7554/elife.97179.1
Zhou, Z., Han, S. Y., Pardo-Navarro, M., et al. (2024) · eLife · doi:10.7554/elife.97179.1.sa1
Zhou, Z., Han, S. Y., Pardo-Navarro, M., et al. (2024) · eLife · doi:10.7554/elife.97179.1.sa2
Zhou, Z., Han, S. Y., Pardo-Navarro, M., et al. (2024) · eLife · doi:10.7554/elife.97179.1.sa0
GnRH pulse generator activity in mouse models of polycystic ovary syndromePreprint
Zhou, Z., Han, S. Y., Pardo-Navarro, M., Wall, E. G., Desai, R., Vas, S., Handelsman, D. J., & Herbison, A. E. (2024) · eLife · doi:10.7554/elife.97179.2 · Cited by 2
The role of GABA signaling in GnRH neuron migration and function
Mitchell, T. (2020) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/ns71-fn05
UNLOCKING THE POTENTIAL OF RESVERATROL IN MANAGING POLYCYSTIC OVARY SYNDROME: A SYSTEMATIC REVIEW
Bhaskaran, D., ANGAPPAN, S., & SEBASTIAN, S. (2026) · INDIAN DRUGS · doi:10.53879/id.63.06.15459
Leite, A. C. J., & Leite, A. (2004) · Revista Medicina Cutánea Ibero-Latino-Americana
Polycystic Ovary Syndrome in the Peripubertal Period
Witchel, S. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-499-5_13
Metadata
- Authors
- Patel, K., Coffler, M. S., Dahan, M. H., Yoo, R. Y., Lawson, M. A., Malcom, P. J., & Chang, R. J.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Chang, R. Jeffrey
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-11-01
- Volume
- 88
- Issue
- 11
- Pages
- 5456-5461
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2109234158
- Cited by
- 60
- References
- 46
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 7 · 2023: 2 · 2022: 2 · 2020: 1 · 2019: 2 · 2017: 1 · 2016: 4 · 2014: 4 · 2013: 4 · 2012: 2
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (RR00827, MO1 RR00827, U54 HD 12303-20)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD012303, U54-HD-12303-20)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, luteinizing hormone secretion, pulsatile LH secretion, insulin resistance, hyperinsulinemia, hyperinsulinemic-euglycemic clamp, GnRH stimulation, gonadotropin secretion, androstenedione, steroidogenesis
- MeSH terms
- Adult, Female, Follicle Stimulating Hormone, Humans, Hyperinsulinism, Hypoglycemic Agents, Insulin, Luteinizing Hormone, Gonadotropin-Releasing Hormone, Polycystic Ovary Syndrome, Pulsatile Flow, Glucose Clamp Technique
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.